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P1-1.
Protein arginine methyltransferase PRMT  1 de-
ciency impairs immune responses to T-cell-inde-
pendent type 2 antigens
:
Development and maturation of B lineage cells are 
tightly regulated by intracellular signaling network.
Activity of these signaling components is modulated by 
post-translational protein modifications, including 
phosphorylation, ubiquitination, and methylation.
Protein arginine methylation catalyzed by protein 
arginine methyltransferases PRMTs  plays a crucial 
role in transcription and signal transduction. To 
examine the role of PRMT1, a major enzyme in 
mammalian cells, in B cells, we established B cell-
specific PRMT1-deficient mice through Cre-lox 
approach.
Development of B cells, but not T cells, was impaired 
in B cell-speci c PRMT1-de cient mice. Concentrations 
of immunoglobulins in sera were also diminished in the 
PRMT1-deficient mice compared with control. NP-
specific IgM antibody responses were decreased in the 
PRMT1-deficient mice following immunization with 
NP-Ficoll or NP-LPS in vivo, whereas NP-speci c IgGs 
antibody responses against NP-OVA were comparable to 
control. NP-speci c IgG3 responses to NP-Ficoll was 
also decreased in PRMT1-deficient mice. Upregulation 
of MHC class II molecule and CD80/86 was comparable 
between PRMT1-deficient and control mice following 
stimulation with anti-IgM, anti-CD40 or LPS. 
Protein arginine methylation catalyzed by PRMT1 
plays a crucial role in antibody responses against T-cell 
independent, but not T-cell dependent antigen in vivo.
P1-2.
IL-27/IL-35
EBI3 IL-23
2
IL-23 Th17
Th17/Th1 Ex-
Th17/Th1
IL-27 IL-35
EBI3
CD4 T
CD4 T RAG
EBI3 CD4 T
IFN-
EBI3 T
IL-12 in vitro Th1
CD4 T IFN-
Th17
IL-1 +IL-6+IL-23 IFN-
GFP-Tg
GFP EBI3 GFP EBI3
EBI3 IFN-
EBI3
73 2178
3
IL-23 R
EBI3 mRNA
IL-23R IL-23
EBI3
p62/SQSTM1
IL-23R IL-23R
IL-23R
EBI3 IL-23R
P1-3.
OVA
JNK c-Jun N-terminal kinase 1
1
MAP mitogen-activated protein 
kinase JNK c-Jun N-terminal 
kinase  
JNK 3
T
JNK JNK
JNK1
JNK1
JNK1 WT JNK1-/-
C57BL/6J OVA
BALF
OVA IgE
ELISA Rag2
JNK1-/- WT
OVA IgE
BALF
IL-4 IL-5
JNK1-/- IL-13
JNK1
T
B WT JNK1-/-
JNK1
P1-4.
JNK cJun 
N-terminal kinase 2
4
c-Jun N-Terminal Kinase 2 JNK2 Mitogen-activated 
Protein Kinases MAPKs
JNK2
JNK2
C57BL/6J JNK2 JNK2-/-
WT
OVA
OVA IgE
ELISA
